Pfiz­er and BioN­Tech urge US patent re­view board to take on Mod­er­na's Covid patents

Pfiz­er and BioN­Tech have once again made their case for the US Patent Tri­al and Ap­peal Board (PT­AB) to weigh in on a Covid-19 patent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.